Medical Care

Global LFA-based Cardiac Marker Market Research Report 2025

The global market for LFA-based Cardiac Marker was valued at US$ 3839 million in the year 2024 and is projected to reach a revised size of US$ 5853 million by 2031, growing at a CAGR of 6.7% during the forecast period.
LFA-based Cardiac Marker is a cardiac marker test based on lateral flow chromatography technology. Lateral flow chromatography technology is a detection method based on the principle of paper chromatography. It is widely used in the detection of disease biomarkers, especially in line with the World Health Organization's REASSURED principle in clinical testing, that is, reasonable cost, high sensitivity, strong specificity, convenient operation, fast and stable, no need for special equipment, easy promotion, real-time feedback, easy sampling, and environmentally friendly. Cardiac markers refer to proteins or enzymes that are released into the peripheral blood and detected during the course of heart disease. They can reflect changes in the structure or function of the heart. Cardiac marker detection based on lateral flow chromatography technology uses the advantages of lateral flow chromatography technology to quickly, accurately and conveniently detect cardiac markers to meet the clinical needs for immediate detection of heart disease.
Market Drivers
Rising Prevalence of Cardiovascular Diseases:
The prevalence of cardiovascular diseases is increasing globally, especially in low- and middle-income countries. This has led to an increase in demand for cardiac marker testing, as cardiac marker testing plays an important role in early diagnosis, risk assessment, and treatment monitoring of heart disease.
Technological Advances and Cost Reductions:
With the advancement of science and technology, the sensitivity and specificity of lateral flow chromatography technology has continued to improve, while the cost of testing has gradually decreased. This has made cardiac marker testing based on lateral flow chromatography technology more popular and acceptable, further driving the development of the market.
Growing Demand for Home Testing:
Home testing (also known as self-testing) allows users to test self-collected samples and obtain results without the assistance of trained medical professionals. This testing method plays an important role in cardiovascular diseases and infectious diseases. With the improvement of consumers' health awareness and the popularity of home testing products, the demand for cardiac marker home testing products based on lateral flow chromatography technology is also increasing.
Support from policies and regulations:
The policy support of governments for medical health and technological innovation has provided a good policy environment for the development of the cardiac marker testing market based on lateral flow chromatography technology. For example, the government may introduce relevant policies to encourage innovation, reduce testing costs, and improve testing accuracy, thereby promoting the development of the market.
Population aging and increased medical needs:
As the global population ages, the elderly population's demand for medical and health services continues to increase. Heart disease is one of the common chronic diseases among the elderly, so the application prospects of cardiac marker detection based on lateral flow chromatography technology in the elderly population are broad.
In summary, the development of the cardiac marker detection market based on lateral flow chromatography technology is driven by a variety of factors, including the increase in the prevalence of cardiovascular diseases, technological advances and cost reductions, the growth of home testing needs, policy and regulatory support, and the aging population and increased medical needs. These factors have jointly promoted the rapid development and widespread application of the market.
This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac Marker.
The LFA-based Cardiac Marker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global LFA-based Cardiac Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LFA-based Cardiac Marker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
Segment by Type
Troponin
CK-MB
Myoglobin
Others
Segment by Application
Laboratory Testing
Point-of-care Testing
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LFA-based Cardiac Marker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Troponin
1.2.3 CK-MB
1.2.4 Myoglobin
1.2.5 Others
1.3 Market by Application
1.3.1 Global LFA-based Cardiac Marker Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global LFA-based Cardiac Marker Market Perspective (2020-2031)
2.2 Global LFA-based Cardiac Marker Growth Trends by Region
2.2.1 Global LFA-based Cardiac Marker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 LFA-based Cardiac Marker Historic Market Size by Region (2020-2025)
2.2.3 LFA-based Cardiac Marker Forecasted Market Size by Region (2026-2031)
2.3 LFA-based Cardiac Marker Market Dynamics
2.3.1 LFA-based Cardiac Marker Industry Trends
2.3.2 LFA-based Cardiac Marker Market Drivers
2.3.3 LFA-based Cardiac Marker Market Challenges
2.3.4 LFA-based Cardiac Marker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LFA-based Cardiac Marker Players by Revenue
3.1.1 Global Top LFA-based Cardiac Marker Players by Revenue (2020-2025)
3.1.2 Global LFA-based Cardiac Marker Revenue Market Share by Players (2020-2025)
3.2 Global Top LFA-based Cardiac Marker Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by LFA-based Cardiac Marker Revenue
3.4 Global LFA-based Cardiac Marker Market Concentration Ratio
3.4.1 Global LFA-based Cardiac Marker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Marker Revenue in 2024
3.5 Global Key Players of LFA-based Cardiac Marker Head office and Area Served
3.6 Global Key Players of LFA-based Cardiac Marker, Product and Application
3.7 Global Key Players of LFA-based Cardiac Marker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 LFA-based Cardiac Marker Breakdown Data by Type
4.1 Global LFA-based Cardiac Marker Historic Market Size by Type (2020-2025)
4.2 Global LFA-based Cardiac Marker Forecasted Market Size by Type (2026-2031)
5 LFA-based Cardiac Marker Breakdown Data by Application
5.1 Global LFA-based Cardiac Marker Historic Market Size by Application (2020-2025)
5.2 Global LFA-based Cardiac Marker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America LFA-based Cardiac Marker Market Size (2020-2031)
6.2 North America LFA-based Cardiac Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America LFA-based Cardiac Marker Market Size by Country (2020-2025)
6.4 North America LFA-based Cardiac Marker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LFA-based Cardiac Marker Market Size (2020-2031)
7.2 Europe LFA-based Cardiac Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe LFA-based Cardiac Marker Market Size by Country (2020-2025)
7.4 Europe LFA-based Cardiac Marker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LFA-based Cardiac Marker Market Size (2020-2031)
8.2 Asia-Pacific LFA-based Cardiac Marker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2020-2025)
8.4 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LFA-based Cardiac Marker Market Size (2020-2031)
9.2 Latin America LFA-based Cardiac Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America LFA-based Cardiac Marker Market Size by Country (2020-2025)
9.4 Latin America LFA-based Cardiac Marker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LFA-based Cardiac Marker Market Size (2020-2031)
10.2 Middle East & Africa LFA-based Cardiac Marker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2020-2025)
10.4 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche LFA-based Cardiac Marker Introduction
11.1.4 Roche Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott LFA-based Cardiac Marker Introduction
11.2.4 Abbott Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens LFA-based Cardiac Marker Introduction
11.3.4 Siemens Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.3.5 Siemens Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher LFA-based Cardiac Marker Introduction
11.4.4 Danaher Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.4.5 Danaher Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories LFA-based Cardiac Marker Introduction
11.5.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 BioMérieux
11.6.1 BioMérieux Company Details
11.6.2 BioMérieux Business Overview
11.6.3 BioMérieux LFA-based Cardiac Marker Introduction
11.6.4 BioMérieux Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.6.5 BioMérieux Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher LFA-based Cardiac Marker Introduction
11.7.4 Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.7.5 Thermo Fisher Recent Development
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Details
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Marker Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.8.5 Ortho Clinical Diagnostics Recent Development
11.9 LSI Medience Corporation
11.9.1 LSI Medience Corporation Company Details
11.9.2 LSI Medience Corporation Business Overview
11.9.3 LSI Medience Corporation LFA-based Cardiac Marker Introduction
11.9.4 LSI Medience Corporation Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.9.5 LSI Medience Corporation Recent Development
11.10 Randox laboratories
11.10.1 Randox laboratories Company Details
11.10.2 Randox laboratories Business Overview
11.10.3 Randox laboratories LFA-based Cardiac Marker Introduction
11.10.4 Randox laboratories Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.10.5 Randox laboratories Recent Development
11.11 Wondfo Biotech
11.11.1 Wondfo Biotech Company Details
11.11.2 Wondfo Biotech Business Overview
11.11.3 Wondfo Biotech LFA-based Cardiac Marker Introduction
11.11.4 Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2020-2025)
11.11.5 Wondfo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global LFA-based Cardiac Marker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Troponin
Table 3. Key Players of CK-MB
Table 4. Key Players of Myoglobin
Table 5. Key Players of Others
Table 6. Global LFA-based Cardiac Marker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global LFA-based Cardiac Marker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global LFA-based Cardiac Marker Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global LFA-based Cardiac Marker Market Share by Region (2020-2025)
Table 10. Global LFA-based Cardiac Marker Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global LFA-based Cardiac Marker Market Share by Region (2026-2031)
Table 12. LFA-based Cardiac Marker Market Trends
Table 13. LFA-based Cardiac Marker Market Drivers
Table 14. LFA-based Cardiac Marker Market Challenges
Table 15. LFA-based Cardiac Marker Market Restraints
Table 16. Global LFA-based Cardiac Marker Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global LFA-based Cardiac Marker Market Share by Players (2020-2025)
Table 18. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2024)
Table 19. Ranking of Global Top LFA-based Cardiac Marker Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by LFA-based Cardiac Marker Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of LFA-based Cardiac Marker, Headquarters and Area Served
Table 22. Global Key Players of LFA-based Cardiac Marker, Product and Application
Table 23. Global Key Players of LFA-based Cardiac Marker, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global LFA-based Cardiac Marker Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global LFA-based Cardiac Marker Revenue Market Share by Type (2020-2025)
Table 27. Global LFA-based Cardiac Marker Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global LFA-based Cardiac Marker Revenue Market Share by Type (2026-2031)
Table 29. Global LFA-based Cardiac Marker Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global LFA-based Cardiac Marker Revenue Market Share by Application (2020-2025)
Table 31. Global LFA-based Cardiac Marker Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global LFA-based Cardiac Marker Revenue Market Share by Application (2026-2031)
Table 33. North America LFA-based Cardiac Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America LFA-based Cardiac Marker Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America LFA-based Cardiac Marker Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe LFA-based Cardiac Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe LFA-based Cardiac Marker Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe LFA-based Cardiac Marker Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific LFA-based Cardiac Marker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America LFA-based Cardiac Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America LFA-based Cardiac Marker Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America LFA-based Cardiac Marker Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa LFA-based Cardiac Marker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2026-2031) & (US$ Million)
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche LFA-based Cardiac Marker Product
Table 51. Roche Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Abbott Company Details
Table 54. Abbott Business Overview
Table 55. Abbott LFA-based Cardiac Marker Product
Table 56. Abbott Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 57. Abbott Recent Development
Table 58. Siemens Company Details
Table 59. Siemens Business Overview
Table 60. Siemens LFA-based Cardiac Marker Product
Table 61. Siemens Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 62. Siemens Recent Development
Table 63. Danaher Company Details
Table 64. Danaher Business Overview
Table 65. Danaher LFA-based Cardiac Marker Product
Table 66. Danaher Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 67. Danaher Recent Development
Table 68. Bio-Rad Laboratories Company Details
Table 69. Bio-Rad Laboratories Business Overview
Table 70. Bio-Rad Laboratories LFA-based Cardiac Marker Product
Table 71. Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 72. Bio-Rad Laboratories Recent Development
Table 73. BioMérieux Company Details
Table 74. BioMérieux Business Overview
Table 75. BioMérieux LFA-based Cardiac Marker Product
Table 76. BioMérieux Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 77. BioMérieux Recent Development
Table 78. Thermo Fisher Company Details
Table 79. Thermo Fisher Business Overview
Table 80. Thermo Fisher LFA-based Cardiac Marker Product
Table 81. Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 82. Thermo Fisher Recent Development
Table 83. Ortho Clinical Diagnostics Company Details
Table 84. Ortho Clinical Diagnostics Business Overview
Table 85. Ortho Clinical Diagnostics LFA-based Cardiac Marker Product
Table 86. Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 87. Ortho Clinical Diagnostics Recent Development
Table 88. LSI Medience Corporation Company Details
Table 89. LSI Medience Corporation Business Overview
Table 90. LSI Medience Corporation LFA-based Cardiac Marker Product
Table 91. LSI Medience Corporation Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 92. LSI Medience Corporation Recent Development
Table 93. Randox laboratories Company Details
Table 94. Randox laboratories Business Overview
Table 95. Randox laboratories LFA-based Cardiac Marker Product
Table 96. Randox laboratories Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 97. Randox laboratories Recent Development
Table 98. Wondfo Biotech Company Details
Table 99. Wondfo Biotech Business Overview
Table 100. Wondfo Biotech LFA-based Cardiac Marker Product
Table 101. Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 102. Wondfo Biotech Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report


List of Figures
Figure 1. LFA-based Cardiac Marker Picture
Figure 2. Global LFA-based Cardiac Marker Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global LFA-based Cardiac Marker Market Share by Type: 2024 VS 2031
Figure 4. Troponin Features
Figure 5. CK-MB Features
Figure 6. Myoglobin Features
Figure 7. Others Features
Figure 8. Global LFA-based Cardiac Marker Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global LFA-based Cardiac Marker Market Share by Application: 2024 VS 2031
Figure 10. Laboratory Testing Case Studies
Figure 11. Point-of-care Testing Case Studies
Figure 12. LFA-based Cardiac Marker Report Years Considered
Figure 13. Global LFA-based Cardiac Marker Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global LFA-based Cardiac Marker Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global LFA-based Cardiac Marker Market Share by Region: 2024 VS 2031
Figure 16. Global LFA-based Cardiac Marker Market Share by Players in 2024
Figure 17. Global LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by LFA-based Cardiac Marker Revenue in 2024
Figure 19. North America LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America LFA-based Cardiac Marker Market Share by Country (2020-2031)
Figure 21. United States LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe LFA-based Cardiac Marker Market Share by Country (2020-2031)
Figure 25. Germany LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific LFA-based Cardiac Marker Market Share by Region (2020-2031)
Figure 33. China LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America LFA-based Cardiac Marker Market Share by Country (2020-2031)
Figure 41. Mexico LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa LFA-based Cardiac Marker Market Share by Country (2020-2031)
Figure 45. Turkey LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE LFA-based Cardiac Marker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Roche Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 49. Abbott Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 50. Siemens Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 51. Danaher Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 53. BioMérieux Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 54. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 55. Ortho Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 56. LSI Medience Corporation Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 57. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 58. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies